{
    "id": 30512,
    "fullName": "EGFR S768_V769delinsIL",
    "impact": "indel",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR S768_V769delinsIL results in a deletion of two amino acids in the protein kinase domain of the Egfr protein from aa 768 to aa 769, combined with the insertion of an isoleucine (I) and a leucine (L) at the same site (UniProt.org). S768_V769delinsIL results in increased phosphorylation of Egfr and downstream Erk1/2 and Akt in cultured cells, and is associated with EGFR inhibitor resistance (PMID: 31911548)",
            "references": [
                {
                    "id": 17999,
                    "pubMedId": 31911548,
                    "title": "Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31911548"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "S768_V769delinsIL",
    "createDate": "07/16/2019",
    "updateDate": "03/03/2020",
    "referenceTranscriptCoordinates": {
        "id": 180898,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181311_55181316delinsATCCTT",
        "cDna": "c.2302_2307delinsATCCTT",
        "protein": "p.S768_V769delinsIL",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20113,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment resulted in progressive disease with a progression-free survival of 3 months in a patient with non-small cell lung cancer harboring EGFR S768_V769delinsIL (PMID: 31715539).",
            "molecularProfile": {
                "id": 32704,
                "profileName": "EGFR S768_V769delinsIL"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17697,
                    "pubMedId": 31715539,
                    "title": "Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31715539"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 17635,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, EGFR S768_V769delinsIL was detected in the pre-treatment biopsy of the brain metastasis from a patient with lung adenocarcinoma, who did not respond to Iressa (gefitinib) treatment (PMID: 17045698).",
            "molecularProfile": {
                "id": 32704,
                "profileName": "EGFR S768_V769delinsIL"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 15704,
                    "pubMedId": 17045698,
                    "title": "Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769L.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17045698"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20709,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, expression of EGFR S768_V769delinsIL conferred resistance to growth inhibition by Tagrisso (osimertinib) in non-small cell lung cancer cells harboring an EGFR exon 19 deletion in culture (PMID: 31911548).",
            "molecularProfile": {
                "id": 35298,
                "profileName": "EGFR exon 19 del EGFR S768_V769delinsIL"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 17999,
                    "pubMedId": 31911548,
                    "title": "Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31911548"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32704,
            "profileName": "EGFR S768_V769delinsIL",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35298,
            "profileName": "EGFR exon 19 del EGFR S768_V769delinsIL",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 180898,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181311_55181316delinsATCCTT",
            "cDna": "c.2302_2307delinsATCCTT",
            "protein": "p.S768_V769delinsIL",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}